SNMMI, the World Molecular Imaging Society (WMIS), and the American College of Radiology (ACR) are recommending that the Centers for Medicare and Medicaid Services (CMS) reconsider the current restrictive coverage policy for NaF PET imaging to identify bone metastases, which can inform treatment strategy. The limited coverage policy became more restrictive on December 14, 2017, when CMS closed the National Oncologic PET Registry (NOPR). {read more here}

A team at the Stanford University School of Medicine developed a PET imaging agent that can predict a tumor’s response to a widely-used lung cancer drug with more than 80 percent accuracy. {read more here}

Using [PET] nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine. {read more here}

Researchers have developed a same-day, noninvasive positron emission tomography (PET)-based imaging approach to assess PD-L1 positive tumors, and the study is presented in the featured article of The Journal of Nuclear Medicine’s March issue. {read more here}